BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22856670)

  • 1. Chemotherapy-related changes in central nervous system phospholipids and neurocognitive function in childhood acute lymphoblastic leukemia.
    Krull KR; Hockenberry MJ; Miketova P; Carey M; Moore IM
    Leuk Lymphoma; 2013 Mar; 54(3):535-40. PubMed ID: 22856670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
    Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
    Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative changes in cerebral spinal fluid phosphatidylcholine during treatment for acute lymphoblastic leukemia.
    Miketova P; Kaemingk K; Hockenberry M; Pasvogel A; Hutter J; Krull K; Moore IM
    Biol Res Nurs; 2005 Jan; 6(3):187-95. PubMed ID: 15583359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of baseline neurocognitive assessment using Cogstate during the first month of therapy for childhood leukemia.
    Sands SA; Harel BT; Savone M; Kelly K; Vijayanathan V; Welch JG; Vrooman L; Silverman LB; Cole PD
    Support Care Cancer; 2017 Feb; 25(2):449-457. PubMed ID: 27726029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.
    Spiegler BJ; Kennedy K; Maze R; Greenberg ML; Weitzman S; Hitzler JK; Nathan PC
    J Clin Oncol; 2006 Aug; 24(24):3858-64. PubMed ID: 16921038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of neurocognitive functioning in children previously randomly assigned to intrathecal methotrexate compared with triple intrathecal therapy for the treatment of childhood acute lymphoblastic leukemia.
    Kadan-Lottick NS; Brouwers P; Breiger D; Kaleita T; Dziura J; Northrup V; Chen L; Nicoletti M; Bostrom B; Stork L; Neglia JP
    J Clin Oncol; 2009 Dec; 27(35):5986-92. PubMed ID: 19884541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of neurocognitive function in long-term survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only.
    Liu W; Cheung YT; Conklin HM; Jacola LM; Srivastava D; Nolan VG; Zhang H; Gurney JG; Huang IC; Robison LL; Pui CH; Hudson MM; Krull KR
    J Cancer Surviv; 2018 Jun; 12(3):398-406. PubMed ID: 29484542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress and executive function in children receiving chemotherapy for acute lymphoblastic leukemia.
    Caron JE; Krull KR; Hockenberry M; Jain N; Kaemingk K; Moore IM
    Pediatr Blood Cancer; 2009 Oct; 53(4):551-6. PubMed ID: 19499584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid concentrations of nitrate plus nitrite during the treatment of acute lymphoblastic leukaemia in childhood.
    Surtees R; Clelland J; Heales S
    Leuk Res; 1998 Aug; 22(8):751-4. PubMed ID: 9680103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of genetic factors on long-term treatment related neurocognitive complications, and on anxiety and depression in survivors of childhood acute lymphoblastic leukemia: The Petale study.
    Petrykey K; Lippé S; Robaey P; Sultan S; Laniel J; Drouin S; Bertout L; Beaulieu P; St-Onge P; Boulet-Craig A; Rezgui A; Yasui Y; Sapkota Y; Krull KR; Hudson MM; Laverdière C; Sinnett D; Krajinovic M
    PLoS One; 2019; 14(6):e0217314. PubMed ID: 31181069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal Assessment of Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated on a Contemporary Chemotherapy Protocol.
    Jacola LM; Krull KR; Pui CH; Pei D; Cheng C; Reddick WE; Conklin HM
    J Clin Oncol; 2016 Apr; 34(11):1239-47. PubMed ID: 26858334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognitive outcomes in long-term survivors of childhood acute lymphoblastic leukemia treated on contemporary treatment protocols: A systematic review.
    Cheung YT; Krull KR
    Neurosci Biobehav Rev; 2015 Jun; 53():108-20. PubMed ID: 25857254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurocognitive Outcome in Very Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia After Treatment with Chemotherapy Only.
    Kanellopoulos A; Andersson S; Zeller B; Tamnes CK; Fjell AM; Walhovd KB; Westlye LT; Fosså SD; Ruud E
    Pediatr Blood Cancer; 2016 Jan; 63(1):133-8. PubMed ID: 26312396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Cross-sectional Study of Two Chemotherapy Protocols on Long Term Neurocognitive Functions in Egyptian Children Surviving Acute Lymphoblastic Leukemia.
    Sherief LM; Sanad R; ElHaddad A; Shebl A; Abdelkhalek ER; Elsafy ER; Hassan TH; Raafat N; Kamal NM; Attia EI
    Curr Pediatr Rev; 2018; 14(4):253-260. PubMed ID: 30381081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability in methotrexate serum and cerebrospinal fluid pharmacokinetics in children with acute lymphocytic leukemia: relation to assay methodology and physiological variables.
    Seidel H; Andersen A; Kvaløy JT; Nygaard R; Moe PJ; Jacobsen G; Lindqvist B; Slørdal L
    Leuk Res; 2000 Mar; 24(3):193-9. PubMed ID: 10739001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemia.
    Iuvone L; Mariotti P; Colosimo C; Guzzetta F; Ruggiero A; Riccardi R
    Cancer; 2002 Dec; 95(12):2562-70. PubMed ID: 12467071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Late sequelae of central nervous system prophylaxis in children with acute lymphoblastic leukemia: high doses of intravenous methotrexate versus radiotherapy of the central nervous system--review of literature].
    Zając-Spychała O; Wachowiak J
    Med Wieku Rozwoj; 2012; 16(2):128-37. PubMed ID: 22971657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folate homeostasis in cerebrospinal fluid during therapy for acute lymphoblastic leukemia.
    Cole PD; Beckwith KA; Vijayanathan V; Roychowdhury S; Smith AK; Kamen BA
    Pediatr Neurol; 2009 Jan; 40(1):34-41. PubMed ID: 19068252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CNS late-effects after ALL therapy in childhood. Part III: neuropsychological performance in long-term survivors of childhood ALL: impairments of concentration, attention, and memory.
    Langer T; Martus P; Ottensmeier H; Hertzberg H; Beck JD; Meier W
    Med Pediatr Oncol; 2002 May; 38(5):320-8. PubMed ID: 11979456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Cerebrospinal Fluid Biomarkers of Central Nervous System Injury With Neurocognitive and Brain Imaging Outcomes in Children Receiving Chemotherapy for Acute Lymphoblastic Leukemia.
    Cheung YT; Khan RB; Liu W; Brinkman TM; Edelmann MN; Reddick WE; Pei D; Panoskaltsis-Mortari A; Srivastava D; Cheng C; Robison LL; Hudson MM; Pui CH; Krull KR
    JAMA Oncol; 2018 Jul; 4(7):e180089. PubMed ID: 29596541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.